The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibody Drug Conjugate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Antibody Drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antibody Drug Conjugate market size is estimated to be worth US$ 1746 million in 2021 and is forecast to a readjusted size of USD 2803.7 million by 2028 with a CAGR of 7.0% during review period. Hospital accounting for % of the Antibody Drug Conjugate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Adcetris segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibody Drug Conjugate include Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibody Drug Conjugate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adcetris
Kadcyl
Other
Market segment by Application can be divided into
Hospital
Pharmaceutical Company
Research Institutions
The key market players for global Antibody Drug Conjugate market are listed below:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody Drug Conjugate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody Drug Conjugate, with price, sales, revenue and global market share of Antibody Drug Conjugate from 2019 to 2022.
Chapter 3, the Antibody Drug Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody Drug Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibody Drug Conjugate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugate.
Chapter 13, 14, and 15, to describe Antibody Drug Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Antibody Drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antibody Drug Conjugate market size is estimated to be worth US$ 1746 million in 2021 and is forecast to a readjusted size of USD 2803.7 million by 2028 with a CAGR of 7.0% during review period. Hospital accounting for % of the Antibody Drug Conjugate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Adcetris segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibody Drug Conjugate include Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibody Drug Conjugate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adcetris
Kadcyl
Other
Market segment by Application can be divided into
Hospital
Pharmaceutical Company
Research Institutions
The key market players for global Antibody Drug Conjugate market are listed below:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody Drug Conjugate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody Drug Conjugate, with price, sales, revenue and global market share of Antibody Drug Conjugate from 2019 to 2022.
Chapter 3, the Antibody Drug Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody Drug Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibody Drug Conjugate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugate.
Chapter 13, 14, and 15, to describe Antibody Drug Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Antibody Drug Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody Drug Conjugate Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Adcetris
1.2.3 Kadcyl
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody Drug Conjugate Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmaceutical Company
1.3.4 Research Institutions
1.4 Global Antibody Drug Conjugate Market Size & Forecast
1.4.1 Global Antibody Drug Conjugate Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibody Drug Conjugate Sales in Volume (2017-2028)
1.4.3 Global Antibody Drug Conjugate Price (2017-2028)
1.5 Global Antibody Drug Conjugate Production Capacity Analysis
1.5.1 Global Antibody Drug Conjugate Total Production Capacity (2017-2028)
1.5.2 Global Antibody Drug Conjugate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody Drug Conjugate Market Drivers
1.6.2 Antibody Drug Conjugate Market Restraints
1.6.3 Antibody Drug Conjugate Trends Analysis
2 Manufacturers Profiles
2.1 Seattle Genetics/Takeda
2.1.1 Seattle Genetics/Takeda Details
2.1.2 Seattle Genetics/Takeda Major Business
2.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Product and Services
2.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Antibody Drug Conjugate Product and Services
2.2.4 Roche Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 ImmunoGen
2.3.1 ImmunoGen Details
2.3.2 ImmunoGen Major Business
2.3.3 ImmunoGen Antibody Drug Conjugate Product and Services
2.3.4 ImmunoGen Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Immunomedics
2.4.1 Immunomedics Details
2.4.2 Immunomedics Major Business
2.4.3 Immunomedics Antibody Drug Conjugate Product and Services
2.4.4 Immunomedics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Antibody Drug Conjugate Product and Services
2.5.4 Pfizer Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Celldex Therapeutics
2.6.1 Celldex Therapeutics Details
2.6.2 Celldex Therapeutics Major Business
2.6.3 Celldex Therapeutics Antibody Drug Conjugate Product and Services
2.6.4 Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Millennium Pharmaceuticals
2.7.1 Millennium Pharmaceuticals Details
2.7.2 Millennium Pharmaceuticals Major Business
2.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Product and Services
2.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bayer HealthCare
2.8.1 Bayer HealthCare Details
2.8.2 Bayer HealthCare Major Business
2.8.3 Bayer HealthCare Antibody Drug Conjugate Product and Services
2.8.4 Bayer HealthCare Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mersana Therapeutics
2.9.1 Mersana Therapeutics Details
2.9.2 Mersana Therapeutics Major Business
2.9.3 Mersana Therapeutics Antibody Drug Conjugate Product and Services
2.9.4 Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Heidelberg Pharma
2.10.1 Heidelberg Pharma Details
2.10.2 Heidelberg Pharma Major Business
2.10.3 Heidelberg Pharma Antibody Drug Conjugate Product and Services
2.10.4 Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Oxford BioTherapeutics
2.11.1 Oxford BioTherapeutics Details
2.11.2 Oxford BioTherapeutics Major Business
2.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Product and Services
2.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibody Drug Conjugate Breakdown Data by Manufacturer
3.1 Global Antibody Drug Conjugate Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibody Drug Conjugate Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibody Drug Conjugate
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody Drug Conjugate Manufacturer Market Share in 2021
3.4.2 Top 6 Antibody Drug Conjugate Manufacturer Market Share in 2021
3.5 Global Antibody Drug Conjugate Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibody Drug Conjugate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody Drug Conjugate Market Size by Region
4.1.1 Global Antibody Drug Conjugate Sales in Volume by Region (2017-2028)
4.1.2 Global Antibody Drug Conjugate Revenue by Region (2017-2028)
4.2 North America Antibody Drug Conjugate Revenue (2017-2028)
4.3 Europe Antibody Drug Conjugate Revenue (2017-2028)
4.4 Asia-Pacific Antibody Drug Conjugate Revenue (2017-2028)
4.5 South America Antibody Drug Conjugate Revenue (2017-2028)
4.6 Middle East and Africa Antibody Drug Conjugate Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibody Drug Conjugate Sales in Volume by Type (2017-2028)
5.2 Global Antibody Drug Conjugate Revenue by Type (2017-2028)
5.3 Global Antibody Drug Conjugate Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibody Drug Conjugate Sales in Volume by Application (2017-2028)
6.2 Global Antibody Drug Conjugate Revenue by Application (2017-2028)
6.3 Global Antibody Drug Conjugate Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibody Drug Conjugate Sales by Type (2017-2028)
7.2 North America Antibody Drug Conjugate Sales by Application (2017-2028)
7.3 North America Antibody Drug Conjugate Market Size by Country
7.3.1 North America Antibody Drug Conjugate Sales in Volume by Country (2017-2028)
7.3.2 North America Antibody Drug Conjugate Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody Drug Conjugate Sales by Type (2017-2028)
8.2 Europe Antibody Drug Conjugate Sales by Application (2017-2028)
8.3 Europe Antibody Drug Conjugate Market Size by Country
8.3.1 Europe Antibody Drug Conjugate Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibody Drug Conjugate Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibody Drug Conjugate Sales by Type (2017-2028)
9.2 Asia-Pacific Antibody Drug Conjugate Sales by Application (2017-2028)
9.3 Asia-Pacific Antibody Drug Conjugate Market Size by Region
9.3.1 Asia-Pacific Antibody Drug Conjugate Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibody Drug Conjugate Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibody Drug Conjugate Sales by Type (2017-2028)
10.2 South America Antibody Drug Conjugate Sales by Application (2017-2028)
10.3 South America Antibody Drug Conjugate Market Size by Country
10.3.1 South America Antibody Drug Conjugate Sales in Volume by Country (2017-2028)
10.3.2 South America Antibody Drug Conjugate Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody Drug Conjugate Sales by Type (2017-2028)
11.2 Middle East & Africa Antibody Drug Conjugate Sales by Application (2017-2028)
11.3 Middle East & Africa Antibody Drug Conjugate Market Size by Country
11.3.1 Middle East & Africa Antibody Drug Conjugate Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibody Drug Conjugate Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibody Drug Conjugate and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibody Drug Conjugate
12.3 Antibody Drug Conjugate Production Process
12.4 Antibody Drug Conjugate Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibody Drug Conjugate Typical Distributors
13.3 Antibody Drug Conjugate Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Antibody Drug Conjugate Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antibody Drug Conjugate Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Seattle Genetics/Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Seattle Genetics/Takeda Major Business
Table 5. Seattle Genetics/Takeda Antibody Drug Conjugate Product and Services
Table 6. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Antibody Drug Conjugate Product and Services
Table 10. Roche Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 12. ImmunoGen Major Business
Table 13. ImmunoGen Antibody Drug Conjugate Product and Services
Table 14. ImmunoGen Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 16. Immunomedics Major Business
Table 17. Immunomedics Antibody Drug Conjugate Product and Services
Table 18. Immunomedics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Antibody Drug Conjugate Product and Services
Table 22. Pfizer Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Celldex Therapeutics Major Business
Table 25. Celldex Therapeutics Antibody Drug Conjugate Product and Services
Table 26. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Millennium Pharmaceuticals Major Business
Table 29. Millennium Pharmaceuticals Antibody Drug Conjugate Product and Services
Table 30. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 32. Bayer HealthCare Major Business
Table 33. Bayer HealthCare Antibody Drug Conjugate Product and Services
Table 34. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mersana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Mersana Therapeutics Major Business
Table 37. Mersana Therapeutics Antibody Drug Conjugate Product and Services
Table 38. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Heidelberg Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Heidelberg Pharma Major Business
Table 41. Heidelberg Pharma Antibody Drug Conjugate Product and Services
Table 42. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Oxford BioTherapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Oxford BioTherapeutics Major Business
Table 45. Oxford BioTherapeutics Antibody Drug Conjugate Product and Services
Table 46. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Services
Table 50. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Antibody Drug Conjugate Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Antibody Drug Conjugate Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Antibody Drug Conjugate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Antibody Drug Conjugate Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Antibody Drug Conjugate Production Site of Key Manufacturer
Table 56. Antibody Drug Conjugate New Entrant and Capacity Expansion Plans
Table 57. Antibody Drug Conjugate Mergers & Acquisitions in the Past Five Years
Table 58. Global Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 59. Global Antibody Drug Conjugate Sales by Region (2023-2028) & (K Units)
Table 60. Global Antibody Drug Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Antibody Drug Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 63. Global Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 64. Global Antibody Drug Conjugate Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Antibody Drug Conjugate Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Antibody Drug Conjugate Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Antibody Drug Conjugate Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 69. Global Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 70. Global Antibody Drug Conjugate Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Antibody Drug Conjugate Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Antibody Drug Conjugate Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Antibody Drug Conjugate Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 75. North America Antibody Drug Conjugate Sales by Country (2023-2028) & (K Units)
Table 76. North America Antibody Drug Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Antibody Drug Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 79. North America Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 80. North America Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 81. North America Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 82. Europe Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 83. Europe Antibody Drug Conjugate Sales by Country (2023-2028) & (K Units)
Table 84. Europe Antibody Drug Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Antibody Drug Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 87. Europe Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 88. Europe Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 89. Europe Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Antibody Drug Conjugate Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Antibody Drug Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Antibody Drug Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 98. South America Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 99. South America Antibody Drug Conjugate Sales by Country (2023-2028) & (K Units)
Table 100. South America Antibody Drug Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Antibody Drug Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 103. South America Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 104. South America Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 105. South America Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Antibody Drug Conjugate Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Antibody Drug Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Antibody Drug Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Antibody Drug Conjugate Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Antibody Drug Conjugate Sales by Application (2023-2028) & (K Units)
Table 114. Antibody Drug Conjugate Raw Material
Table 115. Key Manufacturers of Antibody Drug Conjugate Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Antibody Drug Conjugate Typical Distributors
Table 119. Antibody Drug Conjugate Typical Customers
List of Figures
Figure 1. Antibody Drug Conjugate Picture
Figure 2. Global Antibody Drug Conjugate Revenue Market Share by Type in 2021
Figure 3. Adcetris
Figure 4. Kadcyl
Figure 5. Other
Figure 6. Global Antibody Drug Conjugate Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Pharmaceutical Company
Figure 9. Research Institutions
Figure 10. Global Antibody Drug Conjugate Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Antibody Drug Conjugate Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Antibody Drug Conjugate Sales (2017-2028) & (K Units)
Figure 13. Global Antibody Drug Conjugate Price (2017-2028) & (USD/Unit)
Figure 14. Global Antibody Drug Conjugate Production Capacity (2017-2028) & (K Units)
Figure 15. Global Antibody Drug Conjugate Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Antibody Drug Conjugate Market Drivers
Figure 17. Antibody Drug Conjugate Market Restraints
Figure 18. Antibody Drug Conjugate Market Trends
Figure 19. Global Antibody Drug Conjugate Sales Market Share by Manufacturer in 2021
Figure 20. Global Antibody Drug Conjugate Revenue Market Share by Manufacturer in 2021
Figure 21. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Antibody Drug Conjugate Sales Market Share by Region (2017-2028)
Figure 25. Global Antibody Drug Conjugate Revenue Market Share by Region (2017-2028)
Figure 26. North America Antibody Drug Conjugate Revenue (2017-2028) & (USD Million)
Figure 27. Europe Antibody Drug Conjugate Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Antibody Drug Conjugate Revenue (2017-2028) & (USD Million)
Figure 29. South America Antibody Drug Conjugate Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Antibody Drug Conjugate Revenue (2017-2028) & (USD Million)
Figure 31. Global Antibody Drug Conjugate Sales Market Share by Type (2017-2028)
Figure 32. Global Antibody Drug Conjugate Revenue Market Share by Type (2017-2028)
Figure 33. Global Antibody Drug Conjugate Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 35. Global Antibody Drug Conjugate Revenue Market Share by Application (2017-2028)
Figure 36. Global Antibody Drug Conjugate Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Antibody Drug Conjugate Sales Market Share by Type (2017-2028)
Figure 38. North America Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 39. North America Antibody Drug Conjugate Sales Market Share by Country (2017-2028)
Figure 40. North America Antibody Drug Conjugate Revenue Market Share by Country (2017-2028)
Figure 41. United States Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Antibody Drug Conjugate Sales Market Share by Type (2017-2028)
Figure 45. Europe Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 46. Europe Antibody Drug Conjugate Sales Market Share by Country (2017-2028)
Figure 47. Europe Antibody Drug Conjugate Revenue Market Share by Country (2017-2028)
Figure 48. Germany Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Antibody Drug Conjugate Revenue Market Share by Region (2017-2028)
Figure 57. China Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Antibody Drug Conjugate Sales Market Share by Type (2017-2028)
Figure 64. South America Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 65. South America Antibody Drug Conjugate Sales Market Share by Country (2017-2028)
Figure 66. South America Antibody Drug Conjugate Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Antibody Drug Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Antibody Drug Conjugate in 2021
Figure 78. Manufacturing Process Analysis of Antibody Drug Conjugate
Figure 79. Antibody Drug Conjugate Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
